| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $188.1M | — | +41.0% |
| R&D Expense | $19.4M | — | +14.9% |
| SG&A Expense | $40.0M | — | +20.9% |
| Operating Income | $10.8M | — | +198.1% |
| Interest Expense | $300K | — | -57.1% |
| Pre-tax Income | $14.7M | — | +391.2% |
| Income Tax | $2.2M | — | +345.5% |
| Net Income | $12.5M | — | +400.9% |
| EPS (Basic) | $0.10 | — | +433.3% |
| EPS (Diluted) | $0.10 | — | +433.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $311.9M | -5.6% | +63.7% |
| Short-term Investments | $13.2M | -46.6% | -79.7% |
| Accounts Receivable | $40.2M | +15.5% | +19.6% |
| Current Assets | $512.3M | -14.9% | +29.2% |
| Total Assets | $1.16B | -7.3% | +9.6% |
| Current Liabilities | $293.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$15.8M | — | +79.9% |
| Capital Expenditures | $139K | — | -25.7% |
| Investing Cash Flow | $7.7M | — | +103.2% |
| Financing Cash Flow | -$12.6M | — | -207.9% |
| Free Cash Flow | -$16.0M | — | +79.8% |
| +49.8% |
| Total Liabilities | $310.2M | -25.8% | +12.3% |
| Stockholders' Equity | $852.2M | +2.0% | +8.7% |